Found 355 matching trials
iNO as Salvage Treatment of Hypoxemia After TAAD Surgery N/A The purpose of this study was to clarify the possible mechanism of hypoxemi...
Show More Location
Zhongshan hospital Fudan University
Learn More & Join Trial
Comparison of Stavudine Used Alone or in Combination With Didanosine in HIV-Infected Children PHASE2 To evaluate the safety and determine the pharmacokinetic disposition of sta...
Show More Location
Harbor - UCLA Med. Ctr. - Dept. of Peds., Div. of Infectious Diseases
Learn More & Join Trial
Early Inhaled Nitric Oxide for Respiratory Failure in Newborns PHASE3 This prospective, randomized controlled trial tested whether initiating iNO...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial
Pharmacokinetics and Pharmacodynamics of MPA in Stable Renal Transplant Patients N/A Study of the pharmacokinetic and pharmacodynamic variability of mycophenola...
Show More Location
IRCCS Fondazione Policlinico San Matteo
Learn More & Join Trial
Inhaled Nitric Oxide for Preventing Progression in COVID-19 PHASE2 This is a pilot randomized-controlled (2:1) open label investigation of inh...
Show More Location
Tufts Medical Center
Learn More & Join Trial
A Phase II Double-Blind Study of Delavirdine Mesylate ( U-90152 ) in Combination With Zidovudine ( AZT ) and/or Didanosine ( ddI ) Versus AZT and ddI Combination Therapy PHASE2 To determine the safety and anti-HIV activity of delavirdine mesylate ( U-9...
Show More Location
Alabama Therapeutics CRS
Learn More & Join Trial
Assessing Tele-Health Outcomes in Multiyear Extensions of PD Trials N/A An observational study to characterize and compare long-term clinical outco...
Show More Location
CHeT Telemedicine (Site 363)
Learn More & Join Trial
Prospective Observational Study to Characterize Patients Treated at Internal Medicine Clinics N/A Patients referred to internal medicine wards are becoming increasingly comp...
Show More Location
Ospedale San Raffaele
Learn More & Join Trial
A Phase I/II Double-Blind Controlled Trial to Determine the Safety and Immunogenicity of HIV-1 MN rgp160 Immuno AG Vaccine Therapy in HIV-Infected Individuals With Greater Than or Equal to 500/mm3 CD4+ T Cells and 200-400/mm3 CD4+ T Cells PHASE1 To evaluate the safety and immunogenicity of HIV-1 MN rgp160 (Immuno-AG) in...
Show More Learn More & Join Trial
A Study of Azidothymidine in HIV-Infected Children PHASE2 AMENDED 07/07/93: To evaluate whether continuous infusion AZT will impact n...
Show More Location
Children's Hosp of Washington DC / Children's Natl Med Ctr
Learn More & Join Trial